地夫可特全网公布的2024年的最新价格

Introduction: Deflazacort and prednisone/prednisolone can improve muscle strength, improve timed motor function, delay walking impairment, improve lung function, reduce the need for scoliosis surgery, delay the onset of cardiomyopathy and increase survival rates, and are therefore the current standard drugs for the treatment of patients with Duchenne muscular dystrophy (DMD).

The latest price of deflazacort in 2024 announced on the entire website

There are many versions of deflazacort, and the prices are also different. It is developed and produced by PTC Therapeutics, Inc. and is an original drug. What we know so far are the prices of the German and Indian versions. The prices are for reference only.

A box of the German version of deflazacort has a specification of 6mg*100 tablets, and the price is about 600$-900$. A box of the Indian version of deflazacort has a specification of 6mg*100 tablets, and the price is about 300$-500$. The prices of other versions are not yet clear.

Purchase channels for deflazacort

1. Hospital pharmacies: Patients can purchase deflazacort with a doctor’s prescription from hospital pharmacies in countries where it is listed.

2. Online pharmacies: Some certified online pharmacies may provide deflazacort sales services, and patients can search and purchase on these platforms.

3. Go abroad for medical treatment: You can go to a foreign hospital for treatment, and then get deflazacort treatment in the foreign hospital.

When choosing to purchase deflazacort, patients should make sure to choose formal and reliable channels and use it under the guidance of a doctor. At the same time, you can consult your doctor or local medical institution to find out whether there are cost support programs available to reduce financial pressure.

Efficacy of deflazacort

In a study of 196 male patients who were 5 to 15 years old at the start of the trial and had a documented dystrophin gene mutation, deflazacort showed clinically improved strength in many muscles throughout the body at week 12 compared with those taking placebo. At the end of the 52-week trial, mean muscle strength remained generally stable among deflazacort-treated patients.